Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 02'nd May 2025
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent st
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Friday, 02'nd May 2025
WESTLAKE VILLAGE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results
02:33pm, Friday, 02'nd May 2025
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 300 points on Friday.
Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism
01:43pm, Friday, 02'nd May 2025
Nasdaq jumps as Dexcom, Palantir, and ON Semi soar. Jobs report beats forecasts, easing inflation fears and driving US stock market optimism.
Phoenix Motor Inc. Announces Receipt of Nasdaq Listing Delinquency Letter
09:50am, Friday, 02'nd May 2025
ANAHEIM, CA / ACCESS Newswire / May 2, 2025 / Phoenix Motor Inc. (NASDAQ:PEV) (the "Company") today announced that it received a notice (the "Notice") from the Nasdaq Listing Qualifications Department
Thesis*-Backed Fold Celebrates First Bitcoin Financial Services Listing on Nasdaq with Opening Bell Ceremony
09:30am, Friday, 02'nd May 2025
The listing marks a major milestone for Thesis* as it continues to pioneer Bitcoin-native financial innovation, aimed at providing access to crypto products to average consumers NEW YORK , May 2, 2025
SIMPPLE Ltd. Regains Compliance with Nasdaq's Minimum Bid Price Requirement
09:00am, Friday, 02'nd May 2025
Singapore, May 02, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, toda
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Friday, 02'nd May 2025
DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-ba
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Friday, 02'nd May 2025
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Friday, 02'nd May 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for s
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Friday, 02'nd May 2025
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista's board of directors granted three ne
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Friday, 02'nd May 2025
RESEARCH TRIANGLE PARK, N.C., May 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted s
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index moved to the “Neutral” zone on Thursday.
Nasdaq 100: Apple, Amazon Slide After Hours as Forecasts Miss Street Expectations
05:48pm, Thursday, 01'st May 2025
Apple and Amazon dropped after hours as weak Q2 forecasts rattled traders despite strong Q1 results. Tech stocks face pressure from tariffs and cloud risks.
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Thursday, 01'st May 2025
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 i
